A352940 Stock Overview
Enbio Co., Ltd. produces and sells pesticides in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
ENBIO Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,110.00 |
| 52 Week High | ₩3,645.00 |
| 52 Week Low | ₩1,965.00 |
| Beta | 0.90 |
| 1 Month Change | -4.96% |
| 3 Month Change | -8.66% |
| 1 Year Change | -39.80% |
| 3 Year Change | -73.46% |
| 5 Year Change | n/a |
| Change since IPO | -82.70% |
Recent News & Updates
Shareholder Returns
| A352940 | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | -2.3% | -2.8% | -1.9% |
| 1Y | -39.8% | -39.1% | -9.5% |
Return vs Industry: A352940 matched the KR Chemicals industry which returned -39.1% over the past year.
Return vs Market: A352940 underperformed the KR Market which returned -9.5% over the past year.
Price Volatility
| A352940 volatility | |
|---|---|
| A352940 Average Weekly Movement | 3.9% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A352940 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A352940's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | M.J. Lee | www.enbio.co.kr |
Enbio Co., Ltd. produces and sells pesticides in South Korea. It offers fungi-insecticides, fungicides, insecticides, herbicides, plant growth regulars, and fertilizers. The company was founded in 1997 and is headquartered in Gunpo, South Korea.
ENBIO Co., Ltd. Fundamentals Summary
| A352940 fundamental statistics | |
|---|---|
| Market cap | ₩22.82b |
| Earnings (TTM) | -₩3.21b |
| Revenue (TTM) | ₩35.04b |
0.7x
P/S Ratio-7.1x
P/E RatioIs A352940 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A352940 income statement (TTM) | |
|---|---|
| Revenue | ₩35.04b |
| Cost of Revenue | ₩27.06b |
| Gross Profit | ₩7.97b |
| Other Expenses | ₩11.18b |
| Earnings | -₩3.21b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -295.54 |
| Gross Margin | 22.76% |
| Net Profit Margin | -9.17% |
| Debt/Equity Ratio | 36.3% |
How did A352940 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 10:03 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ENBIO Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jongsun Park | Eugene Investment & Securities Co Ltd. |
| Kyuri Kim | Shinhan Investment Corp. |